Developmentally Supportive Care on Neurobehavioral Outcome of Preterm Very Low Birth Weight Neonates (DSC)

June 24, 2016 updated by: DR. VIKRAM DATTA, Lady Hardinge Medical College

Evaluation of the Effect of Application of Developmentally Supportive Care on Neurobehavioral Outcome of Preterm Very Low Birth Weight Neonates

Enrolled neonates will be provided routine supportive care as per existing neonatal intensive care unit (NICU)protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care (DSC).

Study Overview

Status

Unknown

Detailed Description

Enrolled neonates will be provided routine supportive care as per existing NICU protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care (DSC). DSC components will be strictly emphasized on protected sleep, pain and stress assessment and management, activities of daily living (positioning, feeding and skin care), the healing environment. This group will be designated as group B. Both the groups will receive appropriate management for their morbidities as per existing NICU protocols. Both the groups will be followed up till 37 weeks of gestation where in their neurobehavioral assessment will be performed using Neurobehavioural assessment of preterm infants score.

In both the groups all the baseline data regarding antenatal factors will be recorded in a predesigned proforma such as age, gravid, Gestational age, Chorioamnionitis, Prenatal steroids, Multiple pregnancy, maternal comorbidities (preeclampsia, gestational diabetes mellitus), mode of delivery etc.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Delhi, India
        • Recruiting
        • Lady Hardinge Medical College,New Delhi
        • Contact:
        • Principal Investigator:
          • Vikram Datta, MD
    • Delhi
      • New Delhi, Delhi, India, 110001
        • Recruiting
        • Lady Hardinge Medical College
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 8 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All stable preterm very low birth weight babies not on invasive mechanical ventilation
  • Hemodynamically stable
  • Parental consent

Exclusion Criteria:

  • Babies with major congenital anomalies
  • Asphyxia (Apgar score <3 at 5mins).
  • Acute bilirubin encephalopathy
  • Hypoglycemia at enrollment
  • Clinical Chorioamnionitis(fever > 100.4 ◦ f , uterine fundal tenderness, maternal tachycardia (>100/min), fetal tachycardia (>160/min) and purulent or foul amniotic fluid )
  • History of birth trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: developmentally supportive care
enrolled neonates will be provided routine supportive care as per existing NICU protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care(DSC). DSC components will be strictly emphasized on protected sleep, pain and stress assessment and management, activities of daily living (positioning, feeding and skin care), the healing environment. This group will be designated as group B
DSC components will be strictly emphasized on protected sleep, pain and stress assessment and management, activities of daily living (positioning, feeding and skin care), the healing environment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neurobehavioral outcome Of the Preterm Very low birth weight babies
Time Frame: 18 months
Neurobehavioural outcome will be measured by NAPI at 37 weeks of corrected gestational age.
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to achieve full feeds @150ml/kg
Time Frame: 18 months
Time to achieve full feed @150 ml/kg/day will be measured in days.
18 months
Length of hospital stay
Time Frame: 18 months
will be measured in days
18 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of apneic episodes during hospital stay
Time Frame: 18 months
will be measured as per standard definition of neonatal apnea and expressed as numbers.
18 months
IVH Grade 2 or more
Time Frame: 18 months
will be measured using bedside cranial sonogram and classified using Volpe's classification.
18 months
BPD
Time Frame: 18 months
Presence or absence will be noted and mentioned as yes or no.
18 months
NEC Stage 2 or more
Time Frame: 18 months
Will be staged using Bells staging .
18 months
ROP (any stage)
Time Frame: 18 months
Will be graded using standard classification .
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (Anticipated)

June 1, 2017

Study Completion (Anticipated)

June 1, 2017

Study Registration Dates

First Submitted

April 29, 2016

First Submitted That Met QC Criteria

June 24, 2016

First Posted (Estimate)

June 29, 2016

Study Record Updates

Last Update Posted (Estimate)

June 29, 2016

Last Update Submitted That Met QC Criteria

June 24, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Developmental supportive care

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Very Low Birth Weight Baby

Clinical Trials on developmentally supportive care

Subscribe